Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Bristol Myers Squibb Leans On AI ALS Pact As Valuation Question Persists
Bristol-Myers Squibb has expanded its partnership with insitro to develop disease-modifying therapies for ALS, leveraging AI to identify new targets. This collaboration is seen as a move to refresh its pipeline and address unmet medical needs in a complex field. The stock is currently trading below analyst targets and Simply Wall St’s estimated fair value, with investors monitoring the efficiency and progression of these new AI-driven R&D initiatives.